{{Rsnum
|rsid=11858113
|Gene=CASC5
|Chromosome=15
|position=40621979
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=C
|GMAF=0.348
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CASC5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 54.0 | 36.3
| HCB | 4.4 | 36.5 | 59.1
| JPT | 5.3 | 43.4 | 51.3
| YRI | 10.9 | 44.2 | 44.9
| ASW | 7.0 | 49.1 | 43.9
| CHB | 4.4 | 36.5 | 59.1
| CHD | 7.4 | 41.7 | 50.9
| GIH | 16.8 | 50.5 | 32.7
| LWK | 12.7 | 47.3 | 40.0
| MEX | 12.1 | 36.2 | 51.7
| MKK | 17.9 | 51.9 | 30.1
| TSI | 10.8 | 54.9 | 34.3
| HapMapRevision=28
}}{{Venter SNP
|rsid=11858113
|allele=C
|frequency=0.425
|uid=1103645593455
|type=heterozygous_SNP
|hugo=CASC5
|ensembl gene=ENSG00000137812
|ensembl transcript=ENST00000346991
|sift=
|disease=A chromosomal aberration involving CASC5 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with MLL/HRX. May give rise to a MLL-CASC5 fusion protein.
}}

{{ neighbor
| rsid = 2412541
| distance = 337
}}
{{ neighbor
| rsid = 33931006
| distance = 654
}}

{{GET Evidence
|gene=CASC5
|aa_change=Met598Thr
|aa_change_short=M598T
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11858113
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.999
|nblosum100=2
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}